Monoclonal antibody therapeutics for infectious diseases: Beyond normal human immunoglobulin.

Otsubo, Ryota; Yasui, Teruhito

Otsubo, Ryota; Yasui, Teruhito.

Afiliação

Otsubo R; Laboratory of Infectious Diseases and Immunity, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka 567-0085, Japan.
Yasui T; Laboratory of Infectious Diseases and Immunity, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki City, Osaka 567-0085, Japan. Electronic address: tyasui@nibiohn.go.jp.

Pharmacol Ther ; 240: 108233, 2022 12.

Article em En | MEDLINE | ID: mdl-35738431

Assuntos

Tratamento Farmacológico da COVID-19; Doenças Transmissíveis; Humanos; Anticorpos Monoclonais/uso terapêutico; Leucócitos Mononucleares; Anticorpos Neutralizantes/uso terapêutico

Palavras-chave

Antibody therapeutic agent; Antibody therapy; Bacterial infection; Human neutralizing monoclonal antibodies; Infectious diseases; Memory B cells; Viral infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Transmissíveis / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google